Exponential change is shaping a new world of marketing to consumers who have a very short attention span. Pharma is not organized for digital marketing. Being digital isn’t just about technology, it’s about weaving the digital thread into business, operating, and customer models and it’s about taking chances in a regulated industry because other DTC channels are becoming more inefficient. Continue reading
KEY TAKEAWAY: Consumers interested in virtual health represent a significant share of the total US population—68 percent of respondents under age 65 said they were somewhat or very interested in receiving healthcare virtually. These respondents include millennials and baby boomers, many of whom are also caring for the health and other needs of both children and aging parents. Continue reading
KEY TAKEAWAY: Life sciences companies are producing a massive amount of digital content—and it is growing, but lack of a content strategy and objectives puts growing investment and dollars at risk. Only 4% in med tech and 11% in pharma/biotech report they have a clearly documented content strategy that meets their current and future needs (compared to 42% across all industries). Continue reading
Key Takeaway: Online ads are coming under fire for click fraud and debate about their effectiveness, but the one area where pharma digital marketers need to invest is in their product sites and that investment needs continued support. Continue reading
Online advertisers are starting to wonder what exactly they are paying for? In theory, digital marketing is “vastly more efficient” than conventional advertising, because online ads on social media or websites can be tightly targeted at specific audiences. But while more ad dollars will be spent online than on TV for the first time this year, some advertisers “smell a rat.” About 70 percent of marketing executives say they’re dissatisfied with the state of digital marketing , according to the Interactive Advertising Bureau. Continue reading
KEY TAKEAWAY: When companies have a vested interest in “digital health” they are going to release “select” data to try and get more business, but pharma marketers have to ask “why?” and look for real insights to leverage digital health.